Atopic disorders: A vaccine around the corner?

Trends in Immunology

Volumn 22, Issue 11, 2001, Pages 618-626

  Wohlleben, Gisela ^a   Erb, Klaus Joseph ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIALLERGIC AGENT; BACTERIAL VACCINE; CD4 ANTIGEN; OLIGODEOXYNUCLEOTIDE; PLASMID DNA; RECOMBINANT CYTOKINE; VACCINE;

ALLERGY; ASTHMA; ATOPY; BACTERIUM; CLINICAL TRIAL; DENDRITIC CELL; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INCIDENCE; NONHUMAN; PROPHYLAXIS; REGULATORY MECHANISM; REVIEW; TH1 CELL; TH2 CELL; VACCINATION;

ANIMALS; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY, ACTIVE; OLIGODEOXYRIBONUCLEOTIDES; TH1 CELLS; VACCINES; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, INACTIVATED;

EID: 0035499108     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)02055-5     Document Type: Review

References (100)

1. + T cells
2. Transcription factors in lymphocyte development: T and B cells get together
3. Cytokines induce the development of functionally heterogeneous T-helper-cell subsets
4. Lymphokine production by human T cells in disease states
5. IL-13 in allergy: Home at last
6. Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung
7. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
8. Characterization of T-cell subpopulations involved in the pathogenesis of asthma and allergic diseases
9. Atopic disorders: A default pathway in the absence of infection?
10. The influence of infections on the development and severity of allergic disorders
11. T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production
12. Allergen-specific Th1 cells counteract efferent Th2-cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-γ
13. Allergen-specific Th1 cells fail to counterbalance Th2-cell-induced airway hyperreactivity but cause severe airway inflammation
14. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma
15. Development of T-cell memory against inhalant allergens: Risks for the future
16. Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T-cell responses toward the Th2 cytokine profile
17. Development of allergen-specific T-cell memory in atopic and normal children
18. The inverse association between tuberculin responses and atopic disorders
19. Measles and atopy in Guinea-Bissau
20. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study
21. Early childhood infectious diseases and the development of asthma up to school age: A birth cohort study
22. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae
23. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses
24. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice
25. Infection of mice with Mycobacterium bovis Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia
26. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model
27. Early BCG vaccination and reduction in atopy in Guinea-Bissau
28. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria
29. Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies in Childhood
30. Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs
31. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide
32. Exposure to endotoxin or other bacterial components might protect against the development of atopy
33. Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5
34. The role of CpG motifs in innate immunity
35. CpG DNA as a Th1 trigger
36. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation and airway hyperresponsiveness in mice
37. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
38. Long-term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
39. CpG oligodeoxynucleotides do not require Th1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma
40. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-γ production in cells from allergic individuals and inhibit IgE synthesis in vitro
41. Bacterial DNA causes septic shock
42. Chlamydia infections and heart disease linked through antigenic mimicry
43. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis
44. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA
45. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator
46. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle
47. DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines
48. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine
49. DNA vaccines
50. Gene vaccination: Plasmid DNA is more than just a blueprint
51. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization
52. The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine
53. Intradermal gene vaccination down-regulates both arms of the allergic response
54. Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established airway hyperreactivity in a murine asthma model
55. Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice
56. Immunology of DNA vaccines: CpG motifs and antigen presentation
57. Enhancement of cell-mediated immunity against HIV-1 induced by co-innoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12
58. Amplification of T-cell and antibody responses in DNA-based immunization with HIV-1 Nef by co-injection with a GM-CSF expression vector
59. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
60. + T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
61. Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airways function in a murine model of allergen sensitization
62. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice
63. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation and Th2 cytokine expression in mice
64. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia and serum IgE levels
65. Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways
66. IFN-γ-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines and airway eosinophilia in a mouse model of allergic asthma
67. Cancer trial of interleukin-12 halted
68. Distinct dendritic-cell subsets differentially regulate the class of immune response in vivo
69. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo
70. Reciprocal control of T helper cell and dendritic-cell differentiation
71. A monocyte-conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells
72. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability
73. The role of dendritic cells in the induction and regulation of immunity to microbial infection
74. Dendritic cells in cancer immunotherapy
75. Dendritic-cell vaccines for cancer immunotherapy
76. Regulatory T cells: Key controllers of immunologic self-tolerance
77. T regulatory 1 cells: A novel subset of CD4 T cells with immunoregulatory properties
78. Regulatory T-cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
79. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
80. + T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea
81. When engineered to produce latent TGF-β1, antigen-specific T cells down-regulate Th1-cell-mediated autoimmune and Th2-cell-mediated allergic inflammatory processes
82. + T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation
83. T regulatory cells 1 inhibit a Th2-specific response in vivo
84. Designer dendritic cells for tolerance induction: Guided not misguided missiles
85. Long-term clinical efficacy of grass-pollen immunotherapy
86. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
87. Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Phl p1, a major grass pollen allergen
88. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T-cell cultures
89. High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways
90. Suppression of asthma-like responses in different mouse strains by oral tolerance
91. + T cells
92. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: Evidence of safety and efficacy in paediatric patients
93. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma - A double-blind study
94. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy
95. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
96. Pretreatment with allergen prevents immediate hypersensitivity and airway hyperresponsiveness
97. Treatment of cat allergy with T-cell reactive peptides
98. + T cells into Th1 and Th2 subsets
99. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: Amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide
100. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease